| Citation: |
TIAN Fang, HAN Shuo, WANG Cui, MENG Jing. Mechanism of drug-containing serum of Buzhong Yiqi Decoction in inhibiting the activity and vasculogenic mimicry of lung cancer cells[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 9-18. DOI: 10.7619/jcmp.20233417
|
To investigate the effects and mechanisms of drug-containing serum of Buzhong Yiqi Decoction on the activity and vasculogenic mimicry (VM) of lung cancer cells.
Drug-containing serum of Buzhong Yiqi Decoction with low-dose (BZ-L group), medium-dose (BZ-M group), and high-dose (BZ-H group) were prepared through gastric lavage in SD rats to intervene lung cancer cells. CCK-8 assay, Edu cell proliferation assay, cell clone formation assay, cell scratch assay, and Transwell assay were used to detect the effects of Buzhong Yiqi Decoction on the proliferation and migration of lung cancer A549 and HCC827 cells. Flow cytometry was employed to detect the impacts of Buzhong Yiqi Decoction on lung cancer cell apoptosis and cell cycle, and VM experiments in vitro were conducted to assess the effect of Buzhong Yiqi Decoction on angiogenesis in lung cancer cells. Differentially expressed genes between control cells and drug-intervened cells were detected by RNA-seq sequencing. Subcutaneous xenografts in mice were established to evaluate the inhibitory effect of gavage therapy of Buzhong Yiqi Decoction on the growth of lung cancer cells in vivo.
Buzhong Yiqi Decoction inhibited the viability and proliferative activity of A549 and HCC827 cells in a dose-dependent manner, promoted lung cancer cell apoptosis in a dose-dependent manner, and induced G2/M phase arrest. The migration ability of A549 and HCC827 cells was significantly reduced after Buzhong Yiqi Decoction intervention. As the concentration of Buzhong Yiqi Decoction increased, the VM of A549 and HCC827 cells gradually decreased. Compared with control cells, 765 differentially expressed genes were identified in the Buzhong Yiqi Decoction group, with significant downregulation of p-JNK and p-ERK1/2 gene expression. Western blot analysis revealed that the phosphorylation level of the JNK/ERK1/2 signaling pathway in A549 and HCC827 cells was gradually inhibited with increasing concentrations of Buzhong Yiqi Decoction. Buzhong Yiqi Decoction significantly reduced the volume and mass of mouse tumors, increased the apoptosis rate in tumor tissues, decreased the expression of p-JNK, p-ERK1, and p-ERK2, and increased the expression of E-cadherin in tumor tissues.
Buzhong Yiqi Decoction may inhibit the activity and angiogenesis of lung cancer cells by suppressing the activity of the JNK/ERK1/2 signaling pathway.
| [1] |
刘荣凤, 崔彦芝, 徐志宏, 等. 糖尿病合并非小细胞肺癌的临床特征及发病危险因素分析[J]. 实用临床医药杂志, 2021, 25(22): 10-12. doi: 10.7619/jcmp.20211239
|
| [2] |
王昌平, 黄珣, 杨丽, 等. DP方案联合肿瘤抗血管生成药物在非小细胞肺癌治疗中的效果研究[J]. 实用临床医药杂志, 2017, 21(17): 58-60. doi: 10.7619/jcmp.201717017
|
| [3] |
NIU K, CHEN X W, QIN Y, et al. Celecoxib blocks vasculogenic mimicry via an off-target effect to radiosensitize lung cancer cells: an experimental study[J]. Front Oncol, 2021, 11: 697227. doi: 10.3389/fonc.2021.697227
|
| [4] |
SHI F, WU J T, JIA Q H, et al. Relationship between the expression of ARHGAP25 and RhoA in non-small cell lung cancer and vasculogenic mimicry[J]. BMC Pulm Med, 2022, 22(1): 377. doi: 10.1186/s12890-022-02179-5
|
| [5] |
YAO L L, ZHANG D F, ZHAO X L, et al. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype[J]. J Cell Mol Med, 2016, 20(9): 1673-1685. doi: 10.1111/jcmm.12862
|
| [6] |
于建华, 江正龙, 王宁军, 等. 补中益气汤改善癌因性疲乏[J]. 吉林中医药, 2019, 39(7): 886-889. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJL201907013.htm
|
| [7] |
PENG Z Z, WANG J, SHAN B, et al. The long noncoding RNA LINC00312 induces lung adenocarcinoma migration and vasculogenic mimicry through directly binding YBX1[J]. Mol Cancer, 2018, 17(1): 167. doi: 10.1186/s12943-018-0920-z
|
| [8] |
王浩艺, 麦静愔, 平键, 等. 黄芪汤含药血清对血管内皮生长因子诱导的大鼠肝窦内皮细胞增殖、迁移和成管能力的影响及其作用机制[J]. 临床肝胆病杂志, 2022, 38(10): 2279-2285. doi: 10.3969/j.issn.1001-5256.2022.10.015
|
| [9] |
YU W W, DING J, HE M, et al. Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer[J]. Oncogene, 2019, 38(8): 1225-1238. doi: 10.1038/s41388-018-0463-1
|
| [10] |
ZHANG Y, WANG X C, LI A Q, et al. PP2A regulates metastasis and vasculogenic mimicry formation via PI3K/AKT/ZEB1 axis in non-small cell lung cancers[J]. J Pharmacol Sci, 2022, 150(2): 56-66. doi: 10.1016/j.jphs.2022.07.001
|
| [11] |
ZHANG X F, CUI P, DING B C, et al. Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction[J]. Cancer Gene Ther, 2018, 25(1/2): 18-26.
|
| [12] |
BECK M, BARANGER M, MOUFOK-SADOUN A, et al. The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanisms[J]. Oncogene, 2021, 40(3): 522-535. doi: 10.1038/s41388-020-01546-y
|
| [13] |
FU R, DU W W, DING Z L, et al. HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment[J]. Cell Death Dis, 2021, 12(4): 394. doi: 10.1038/s41419-021-03682-z
|
| [14] |
ANTHONYMUTHU S, SABUI S, SHEIKH A, et al. Tumor necrosis factor α impedes colonic thiamin pyrophosphate and free thiamin uptake: involvement of JNK/ERK1/2-mediated pathways[J]. Am J Physiol Cell Physiol, 2022, 323(6): C1664-C1680. doi: 10.1152/ajpcell.00458.2022
|
| [15] |
LEE J, LEE H, JANG S, et al. CMIT/MIT induce apoptosis and inflammation in alveolar epithelial cells through p38/JNK/ERK1/2 signaling pathway[J]. Mol Cell Toxicol, 2019, 15(1): 41-48. doi: 10.1007/s13273-019-0005-0
|
| [16] |
GAO P L, CHEN S, LIU S, et al. Chiral carbon dots-enzyme nanoreactors with enhanced catalytic activity for cancer therapy[J]. ACS Appl Mater Interfaces, 2021, 13(47): 56456-56464. doi: 10.1021/acsami.1c16091
|
| [17] |
EL-SADEK H M, AL-SHORBAGY M Y, AWNY M M, et al. Pentoxifylline treatment alleviates kidney ischemia/reperfusion injury: novel involvement of galectin-3 and ASK-1/JNK & ERK1/2/NF-κB/HMGB-1 trajectories[J]. J Pharmacol Sci, 2021, 146(3): 136-148. doi: 10.1016/j.jphs.2021.03.011
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: